Home › Funds › Sofinnova Investments, Inc. › MIRM

Sofinnova Investments, Inc. position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

Sofinnova Investments, Inc. reported holding 27,591 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$3.2M, representing 0.17% of its reported portfolio and ranking #43 among its reported holdings. Sofinnova Investments, Inc. has disclosed MIRM holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)27.59K sh
Reported value held$3.23M
Portfolio Weight0.17%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s MIRM position evolved

Sofinnova Investments, Inc. first disclosed a stake in MIRM in Q3 2023 at 9,089 shares (US$287K). The position peaked in Q4 2023 at 352,397 shares, worth US$10.4M. Across 6 filings, Sofinnova Investments, Inc. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 27,591 shares valued at US$3.2M. Notable position changes include a 3777% increase in Q4 2023 (shares fell 15% over the following quarter), a 99% trim in Q1 2024 (shares rose 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.09K $287.21K New
Q4 2023 352.40K $10.40M Add
Q1 2024 3.01K $75.66K Reduce
Q4 2025 23.10K $1.82M New
Q1 2026 27.59K $2.55M Add
Q2 2026 27.59K $3.23M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 62 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has Sofinnova Investments, Inc. held MIRM?

Sofinnova Investments, Inc. has disclosed MIRM holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is Sofinnova Investments, Inc.'s current position in MIRM?

As of Q2 2026, Sofinnova Investments, Inc. holds 27.59K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $3.23M, representing 0.17% of its reported portfolio and ranking #43.

Has Sofinnova Investments, Inc. been buying or selling MIRM?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. held unchanged its position in MIRM. The position peaked in Q4 2023 at 352.40K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.